2021
DOI: 10.1080/21506590.25352021plp-r1dnrqa
|View full text |Cite
|
Sign up to set email alerts
|

Regulatory 101: Drug Names – Reader Q&A

Abstract: Medication errors occur in writing, print, speaking, and electronic communications; all of these modes must be considered in development of the drug name. The perspectives of health professionals with product name usage on a daily basis is far different than that of industry personnel who develop drug names for product recognition and commercial marketing.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles